Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

@article{Malanda2012SelfmonitoringOB,
  title={Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.},
  author={Uri{\"e}ll Malanda and Laura M. C. Welschen and Ingrid I. Riphagen and Jacqueline M. Dekker and Giel Nijpels and Sandra D. M. Bot},
  journal={The Cochrane database of systematic reviews},
  year={2012},
  volume={1},
  pages={
          CD005060
        }
}
BACKGROUND Self-monitoring of blood glucose (SMBG) has been found to be effective for patients with type 1 diabetes and for patients with type 2 diabetes using insulin. [] Key MethodSEARCH METHODS Multiple electronic bibliographic and ongoing trial databases were searched supplemented with handsearches of references of retrieved articles (date of last search: 07 July 2011).

Figures from this paper

Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).

It is argued that the use of SMBG in this patient group is questionable, and its unlimited use and promotion should be reconsidered.

Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies

Key publications on SMBG are reviewed to put them into perspective with regard to results of the Cochrane review and current aspects of diabetes management.

Self-Monitoring of Blood Glucose for Patients With Type 2 Diabetes in Primary Care: A Single-Centre, 10-Year Retrospective Analysis

Adherence to the NICE guidelines on SMBG is subpar, and recommended solutions include educating healthcare professionals involved in the prescribing of SMBGs, regular reviews of the continued necessity of SMBG, and digital alerts on e-prescribing systems.

Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement

SMBG is underutilized in patients with T2DM treated or not with insulin, and poor metabolic control and rates of hyper- and hypoglycemia deserve consideration in all treatment groups.

Self-monitoring blood glucose--non-insulin-treated type 2 diabetes in Australian general practice.

Patients with non-insulin-treated type 2 diabetes who test BG daily may be those struggling for control, and associations between SMBG, glycosylated haemoglobin (HbA1c) and body mass index (BMI) are investigated.

Self-monitoring of blood glucose in type 2 diabetes: systematic review.

The evidence suggested that SMBG is of limited clinical effectiveness in improving glycaemic control in people with type 2 diabetes on oral agents, or diet alone, and is therefore unlikely to be cost-effective.

Self-monitoring of blood glucose did not improve HbA1c or QoL at 1 year in noninsulin-treated type 2 diabetes

  • H. Murff
  • Medicine
    Annals of Internal Medicine
  • 2017
Self-monitoring of blood glucose (SMBG), with or without enhanced messaging, vs no SMBG in patients with type 2 diabetes not treated with insulin, did not improve hemoglobin A1c levels or health-related quality of life at 1 year.

Evaluation of Clinical Effectiveness of Self-Monitoring Blood Glucose Level in Patients with Type 2 Diabetes Mellitus Treated with Non-Insulin Regimens in Düzce: Primary Care-Based Study

Evaluated frequency of SMBG and its efficacy among patients with type 2 diabetes in primary care settings in Duzce Province of Turkey found no difference between status of SM BG and glycemic indexes.
...

References

SHOWING 1-10 OF 152 REFERENCES

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

It is concluded that self-monitoring of blood glucose might be effective in improving glycaemic control in patients with type 2 diabetes who are not using insulin.

Self-monitoring of blood glucose and glycaemic control in type 2 diabetes

The use of SMBG was not associated with improved glycaemic control in any therapy category of patients with type 2 diabetes in primary care, and could not be explained by differences in comorbidity between users and non-users of SM BG.

Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).

It is argued that the use of SMBG in this patient group is questionable, and its unlimited use and promotion should be reconsidered.

Systematic Review of the Benefits of Self-Monitoring of Blood Glucose on Glycemic Control in Type 2 Diabetes Patients

This systematic review evaluated the evidence of benefit of SMBG on glycemic control in non–insulin-treated type 2 diabetes and found that SMBG was effective in reducing HbA1c in non-ins insulin-treatedType 2 diabetes.

Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis.

At most, SMBG produces a statistically significant but clinically modest effect in controlling blood glucose levels in patients with DM not taking insulin, and is of questionable value in helping meet target values of glucose control.

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review.

There is now much debate on the effectiveness of self-monitoring of blood glucose (SMBG) as a tool in the self-management of diabetic patients, and it has been suggested that patients with type 2 diabetes who are not using insulin might also benefit from SMBG.

Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis

SMBG compared with non-SMBG is associated with a significantly improved glycaemic control in non-insulin treated patients with type 2 diabetes, and the added value of more frequent SM BG compared with less intensive SMBG remains uncertain.

Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)*

Multi-component diabetes management programs with self-monitoring of blood glucose result in better glycemic control among non-insulin-using type 2 diabetes patients, according to a meta-analysis of the difference in HbA1c reduction between self- Monitoring and non-self- Monitoring groups.

Effects of self-monitoring of glucose in non-insulin treated patients with type 2 diabetes: design of the IN CONTROL-trial

The IN CONTROL-trial is designed to explore whether feedback from self-monitoring of glucose in T2DM patients who do not require insulin can affect diabetes specific emotional distress and increase self-efficacy.
...